Literature DB >> 4911021

L-asparaginase and L-asparagine metabolism.

D A Cooney, R E Handschumacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4911021     DOI： 10.1146/annurev.pa.10.040170.002225

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN： 0066-4251            Impact factor:   13.820


× No keyword cloud information.
  36 in total

1.  Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.

Authors:  Jason R Cantor; Tae Hyeon Yoo; Aakanksha Dixit; Brent L Iverson; Thomas G Forsthuber; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-05       Impact factor: 11.205

Review 2.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Authors:  Jemy A Gutierrez; Yuan-Xiang Pan; Lukasz Koroniak; Jun Hiratake; Michael S Kilberg; Nigel G J Richards
Journal:  Chem Biol       Date:  2006-12

4.  An investigation into the mechanism ofL-asparaginase resistance in L5178Y murine leukemia cells.

Authors:  J K Martin; W Sun; D Moraga-A; S M Schuster; D E Wylie
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

5.  The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Authors:  Jiangbin Ye; Monika Kumanova; Lori S Hart; Kelly Sloane; Haiyan Zhang; Diego N De Panis; Ekaterina Bobrovnikova-Marjon; J Alan Diehl; David Ron; Constantinos Koumenis
Journal:  EMBO J       Date:  2010-05-14       Impact factor: 11.598

6.  The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance.

Authors:  Troy Z Horvat; Joshua J Pecoraro; Ryan J Daley; Larry W Buie; Amber C King; Raajit K Rampal; Martin S Tallman; Jae H Park; Dan Douer
Journal:  Leuk Res       Date:  2016-08-26       Impact factor: 3.156

7.  Purification and Some Biological Properties of Asparaginase from Azotobacter vinelandii.

Authors:  S A Gaffar; Y I Shethna
Journal:  Appl Environ Microbiol       Date:  1977-03       Impact factor: 4.792

8.  Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey.

Authors:  S L Berg; F M Balis; C L McCully; K S Godwin; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.

Authors:  Tadayuki Akagi; Dong Yin; Norihiko Kawamata; Claus R Bartram; Wolf-K Hofmann; Jee Hoon Song; Carl W Miller; Monique L den Boer; H Phillip Koeffler
Journal:  Leuk Res       Date:  2008-12-02       Impact factor: 3.156

10.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.